Cargando…
Mesenchymal Stromal Cell Bioreactor for Ex Vivo Reprogramming of Human Immune Cells
Bone marrow mesenchymal stromal cells (MSCs) have been studied for decades as potent immunomodulators. Clinically, they have shown some promise but with limited success. Here, we report the ability of a scalable hollow fiber bioreactor to effectively maintain ideal MSC function as a single populatio...
Autores principales: | Allen, Ashley, Vaninov, Natalie, Li, Matthew, Nguyen, Sunny, Igo, Peter, Tilles, Arno W., O’Rourke, Brian, Miller, Brian L. K., Parekkadan, Biju, Barcia, Rita N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311545/ https://www.ncbi.nlm.nih.gov/pubmed/32576889 http://dx.doi.org/10.1038/s41598-020-67039-w |
Ejemplares similares
-
Author Correction: Mesenchymal Stromal Cell Bioreactor for Ex Vivo Reprogramming of Human Immune Cells
por: Allen, Ashley, et al.
Publicado: (2020) -
Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular application
por: O'Rourke, Brian, et al.
Publicado: (2021) -
Pharmacological effects of ex vivo mesenchymal stem cell immunotherapy in patients with acute kidney injury and underlying systemic inflammation
por: Swaminathan, Madhav, et al.
Publicado: (2021) -
Convergence of Cell Pharmacology and Drug Delivery
por: Aijaz, Ayesha, et al.
Publicado: (2019) -
Extracorporeal Stromal Cell Therapy for Subjects With Dialysis-Dependent Acute Kidney Injury
por: Miller, Brian L.K., et al.
Publicado: (2018)